10.1002/ejoc.201800139
European Journal of Organic Chemistry
FULL PAPER
1) 2951, 2922, 2850, 1456, 1376, 1138, 1108, 1015, 918; HRMS (ESI) m/z:
[M+H]+ Calcd for C19H31O2 291.2319; found: 291.2324;
heptane/EtOAc (95/5). Both diastereoisomers were not separated. 1H-
NMR (400 MHz, CDCl3): δ 5.90–5.78 (m, 2H), 5.20–5.09 (m, 2H), 4.52–
4.50 (m, 2H), 4.12 (q, J = 7.2 Hz, 4H), 4.08 (dd, J = 11.7 Hz, J = 1.7 Hz,
2H), 3.79 (dd, J = 11.8 Hz, J = 3.5 Hz, 2H), 3.65 (dd, J = 11.8 Hz, J = 2.3
Hz, 1H), 3.60 (dd, J = 11.7 Hz, J = 2.3 Hz, 1H), 3.10 (dd, J = 11.3 Hz, J =
2.4 Hz, 2H), 2.46–2.18 (m, 10H), 2.04–1.80 (m, 6H), 1.65–1.60 (m, 8H),
1.46–1.35 (m, 4H), 1.23 (t, J = 7.2 Hz, 6H), 1.14–1.04 (m, 1H), 0.92–0.81
(m, 2H), 0.77–0.70 (m, 1H), 0.62–0.48 (m, 2H), 0.44–0.38 (m, 1H), 0.30–
0.22 (m, 1H) ppm; 13C-NMR (100 MHz, CDCl3): δ 173.6, 138.7, 137.9,
131.8, 130.8, 102.4, 102.3, 67.1, 67.0, 60.2 (2C), 35.2, 34.5, 34.2 (2C),
33.4, 33.3, 33.0, 28.3, 27.6, 27.0, 26.9, 26.6, 26.1, 24.8 (2C), 23.7,
23.6(2C), 23.5, 22.1, 21.1, 14.2 (2C), (2 peaks underneath CDCl3 peak),
quaternary carbons missing, ppm; IR (cm-1) 2953, 2927, 2855, 1731, 1455,
1404, 1376, 1138, 1102, 1056, 1016, 985, 939; HRMS (ESI) m/z: [M+H]+
Calcd for C19H31O4 323.2217; found: 323.2217.
2'-nonylspiro[bicyclo[6.1.0]nonane-9,5'-[1,3]dioxan]-4-yne
(13d).
Compound 13d was obtained in 18% yield, 12.1 mg (colorless oil) starting
from acetal 12d (90.0 mg, 0.19 mmol) using the general procedure C and
purified by column chromatography eluting heptane/EtOAc (97/3). 1H NMR
(400 MHz, CDCl3): δ 4.54 (t, J = 5.1 Hz, 1H), 4.10 (d, J = 11.4 Hz, 1H),
3.92 (d, J = 11.9 Hz, 1H), 3.80 (dd, J = 11.9 Hz, J = 2.5 Hz, 1H), 3.13 (dd,
J = 11.4 Hz, J = 2.5 Hz, 1H), 2.51–2.46 (m, 1H), 2.36–2.12 (m, 4H), 2.08–
2.03 (m, 1H), 1.69–1.58 (m, 3H), 1.45–1.34 (m, 3H), 1.29–1.23 (m, 12H),
0.96–0.90 (m, 1H), 0.85 (t, J = 7.0 Hz, 3H), 0.63–0.56 (m, 1H) ppm; 13C
NMR (100 MHz, CDCl3): δ 102.8, 99.0, 98.1, 76.6, 67.3, 35.0, 31.8, 29.8,
29.5 (4C), 29.2, 28.2, 27.7, 24.1, 23.0, 22.6, 21.1, 21.0, 14.1 ppm; IR (cm-
1) 2951, 2921, 2851, 1729, 1465, 1376, 1138, 1111, 1015, 938; HRMS
(ESI) m/z: [M+H]+ Calcd for C21H35O2 319.2632; found: 319.2631;
(E)-4-(spiro[bicyclo[6.1.0]non[4]ene-9,5'-[1,3]dioxan]-2'-yl)butan-1-ol
(14f). Compound 14f was obtained in 46% yield, 52.0 mg (pale yellow oil)
starting from the isomer 12f (112 mg, 0.40 mmol) using the general
4-((1R,8S)-spiro[bicyclo[6.1.0]non[4]yne-9,5'-[1,3]dioxan]-2'-yl)butan-
1-ol (13f). Compound 13f was obtained in 30% yield, 8.3 mg (pale yellow
oil) starting from acetal 12f (88.0 mg, 0.314 mmol) using the general
procedure C but only heated for 30 min and purified by column
chromatography eluting heptane/EtOAc (1/1). 1H-NMR (400 MHz, CDCl3):
δ 4.57 (t, J = 5.2 Hz, 1H), 4.13 (d, J = 11.3 Hz, 1H), 3.94 (d, J = 11.8 Hz,
1H), 3.82 (dd, J = 11.9 Hz, J = 2.5 Hz, 1H), 3.63 (t, J = 6.5 Hz, 2H), 3.15
(dd, J = 11.3 Hz, J = 2.5 Hz, 1H), 2.50 (dq, J = 13.4 Hz, J = 3.1Hz, 1H),
2.38–2.15 (m, 4H), 2.04 (dq, J = 13.4 Hz, J = 3.1Hz, 1H), 1.73–1.54 (m,
6H), 1.48–1.36 (m, 5H), 0.95 (ddd, J = 12.7 Hz, J = 8.8 Hz, J = 3.2 Hz, 1H),
0.62 (ddd, J = 12.7 Hz, J = 8.8 Hz, J = 3.2 Hz, 1H) ppm; 13C-NMR (100
MHz, CDCl3): δ 102.6, 99.1, 98.1, 67.3, 62.9, 53.4, 34.9, 32.6, 29.7, 28.2,
27.7, 25.6, 24.1, 23.8, 23.0, 21.1, 21.0 ppm; IR (cm-1) 3424, 2927, 2852,
1723, 1456, 1404, 1377, 1137, 1040, 1011, 937; MS (ESI) m/z [M+H]+
279.4; HRMS (ESI) m/z: [M+H]+ Calcd for C17H27O3 279.1955; found:
279.1953.
procedure
A
and purified by column chromatography eluting
heptane/EtOAc (1/1). Both diastereoisomers were not separated. 1H-NMR
(400 MHz, CDCl3): δ 5.93–5.80 (m, 2H), 5.22–5.09 (m, 2H), 4.55 (m, 2H),
4.10 (dd, J = 11.2 Hz, J = 1.4 Hz, 2H), 3.81 (dd, J = 11.9 Hz, J = 3.6 Hz,
2H), 3.69–3.60 (m, 6H), 3.12 (dd, J = 11.2 Hz, J = 2.4 Hz, 2H), 2.46–2.19
(m, 6H), 2.04–1.79 (m, 6H), 1.65–1.52 (m, 8H), 1.45–1.34 (m, 8H), 1.31–
1.23 (m, 2H), 1.16–1.05 (m, 1H), 0.94–0.82 (m, 2H), 0.79–0.73 (m, 1H),
0.65–0.50 (m, 2H), 0.47–0.40 (m, 1H), 0.32–0.25 (m, 1H) ppm; 13C-NMR
(100 MHz, CDCl3): δ 138.8, 137.9, 131.9, 130.8, 102.6, 102.5, 67.1, 67.0,
62.85 (2C), 35.2, 34.8 (2C), 33.4, 33.3, 33.0, 32.6 (2C), 28.3, 27.6, 27.0,
26.9, 26.6, 26.1, 25.6 (2C), 23.8 (2C), 23.7, 23.5, 22.1, 21.1, (2 peaks
underneath CDCl3 peak) ppm; IR (cm-1) 3415, 2927, 2853, 1136, 1013;
HRMS (ESI) m/z: [M+H]+ Calcd for C17H29O3 281.2111; found: 281.2113.
(E)-2-(spiro[bicyclo[6.1.0]nonane-9,5'-[1,3]dioxan]-4-en-2'-
ylmethoxy)ethyl benzoate (14g). Compound 14g was obtained in 8%
yield, as a colorless oil (5.3 mg) starting from the isomer 12g (64.8mg, 0.17
(E)-2'-pentylspiro[bicyclo[6.1.0]non[4]ene-9,5'-[1,3]dioxane]
(14b).
Compound 14b was obtained in 9% yield, 8.6 mg (pale yellow oil) starting
from the isomer 12b (100 mg, 0.378 mmol) using the general procedure A
and purified by column chromatography eluting heptane/EtOAc (95/5).
Both diastereosiomers were not separated. 1H-NMR (400 MHz, CDCl3): δ
5.93–5.80 (m, 2H), 5.22–5.10 (m, 2H), 4.55–4.51 (m, 2H), 4.10 (dd, J =
11.2 Hz, J = 1.5 Hz, 2H), 3.82 (dd, J = 11.9 Hz, J = 3.6 Hz, 2H), 3.66 (dd,
J = 21.1 Hz, J = 2.5 Hz, 1H), 3.63 (dd, J = 20.7 Hz, J = 2.5 Hz, 1H), 3.13
(dd, J = 11.2 Hz, J = 2.4 Hz, 2H), 2.47–2.19 (m, 6H), 2.05–1.81 (m, 6H),
1.65–1.59(m, 4H), 1.42–1.35 (m, 4H), 1.32–1.25 (m, 8H), 1.16–1.08 (m,
1H), 0.91–0.83 (m, 8H), 0.79–0.73 (m, 1H), 0.65–0.50 (m, 2H), 0.46–0.40
(m, 1H), 0.31–0.24 (m, 1H) ppm; 13C-NMR (100 MHz, CDCl3): δ 138.8,
137.9, 131.9, 130.8, 102.8, 102.7, 67.1, 67.0, 35.2, 34.9, 33.4, 33.3, 33.0,
31.7 (2C), 28.3, 27.6, 27.0, 26.9, 26.6, 26.1, 23.8 (2C), 23.5, 22.5 (2C),
22.1, 21.0, 14.0 (2C), (2 peaks underneath CDCl3 peak), quaternary
carbons missing, ppm; IR (cm-1) 2951, 2926, 2854, 1137, 1016; HRMS
(ESI) m/z: [M+H]+ Calcd for C17H29O2 265.2162; found: 265.2158.
mmol) using the general procedure
A and purified by column
chromatography eluting heptane/EtOAc (8/2). Both diastereoisomers were
not separated. 1H-NMR (400 MHz, CDCl3): δ 8.03 (d, J = 8.0 Hz, 4H), 7.53
(t, J = 7.4 Hz, 2H), 7.41 (t, J = 7.4 Hz, 4H), 5.89–5.77 (m, 2H), 5.19–5.07
(m, 2H), 4.77–4.74 (m, 2H), 4.45 (d, J = 4.5 Hz, 4H), 4.11 (dd, J = 11.2 Hz,
J = 2.0 Hz, 2H), 3.86–3.81 (m, 6H), 3.70–3.58 (m, 6H), 3.13 (dd, J = 11.4
Hz, J = 2.2 Hz, 2H), 2.43–2.16 (m, 6H), 2.02–1.77 (m, 6H), 1.13–1.02 (m,
1H), 0.90–0.79 (m, 2H), 0.77–0.70 (m, 1H), 0.63–0.50 (m, 2H), 0.47–0.39
(m, 1H), 0.30–0.24 (m, 1H) ppm; 13C-NMR (100 MHz, CDCl3): δ 166.5,
138.7, 137.9, 132.9, 131.9, 130.9, 130.0, 129.7 (2C), 128.3 (2C), 100.4,
72.6, 69.7, 67.1, 67.0, 64.1, 35.2, 33.4, 33.3, 33.0, 28.3, 27.6, 27.0, 26.9,
26.6, 26.1, 23.8, 23.5, 22.2, 21.2, (2 peaks underneath CDCl3 peak) ppm;
IR (cm-1) 2924, 2852, 1719, 1452, 1273, 1273, 1136, 1115, 1071, 1055,
713; HRMS (ESI) m/z: [M+H]+ Calcd for C22H29O5 373.2010; found:
373.2006.
(E)-ethyl
5-(spiro[bicyclo[6.1.0]non[4]ene-9,5'-[1,3]dioxan]-2'-
yl)pentanoate (14e). Compound 14e was obtained in 19% yield, 8.6 mg
(pale yellow oil) starting from the isomer 12e (70 mg, 0.21 mmol) using the
general procedure A and purified by column chromatography eluting
Acknowledgements
This article is protected by copyright. All rights reserved.